Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Gross Profit | 13,430 | 12,950 | 12,290 | 14,450 | 12,070 |
| Operating Expenses | 570 | 510 | 520 | 520 | 470 |
| Operating Income | -570 | -510 | -520 | -520 | -470 |
| Pre-tax Income | -570 | -510 | -520 | -520 | -470 |
| Net Income Continuous | -570 | -510 | -520 | -520 | -470 |
| Net Income | $-570 | $-510 | $-520 | $-520 | $-470 |
| EBITDA(a) | $-200 | $N/A | $-100 | $-50 | $0 |